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Abstract.  We have used an in vivo system generating 
assayable amounts of a  specific pre-mRNA to study 
the relationship between splicing and an operationally 
defined nuclear matrix preparation  (NM).  When NM 
is prepared by extraction of DNase I-treated nuclei 
with an approximately physiological concentration of 
KC1 (0.1 M), a portion of NM-associated precursor 
can be spliced in vitro in the presence of ATP and 
Mg  ~÷ and in the absence of splicing extract ("autono- 
mous splicing").  We propose that the autonomous 
reaction,  which does not exhibit a temporal lag and is 
half-complete in 5 min,  occurs in fully assembled, 
matrix-bound ribonucleoprotein complexes (in vivo 
spliceosomes). Extraction of the NM with concentra- 
tions of KC1 >0.4 M  eliminates autonomous splicing 
but leaves behind preassembled complexes that can be 
complemented for splicing with I-IeLa cell nuclear ex- 
tract.  The splicing complementing factor, representing 
one or more activities present in the nuclear extract 
and also in the cytoplasmic S100 fraction,  is relatively 
heat resistant,  devoid of an RNA component,  and does 
not bind to DEAE-Sepharose in 0.1  M  KC1. It exists 
in the nucleus in two forms; bound to autonomous 
spliceosomes and free in the nucleoplasm.  Biochemi- 
cal features of the complementation reaction,  and con- 
ditions for reversible uncoupling of the two splicing 
steps are described and discussed. 
W 
'E have previously developed a model system that 
can be used to examine the potential  involvement 
of the presumptive nucleoskeleton  in nuclear pre- 
mRNA splicing  (Zeitlin  et al.,  1987).  The nucleoskeleton 
(or nuclear scaffold or in situ nuclear matrix)  is thought  to 
be  composed  of the  peripheral  lamina  and  an  internal 
fibrogranular  network that is poorly defined structurally  and 
biochemically (reviewed  by Hancock and Boulikas,  1982; 
Bouteille et al., 1983; Berezney, 1984; Nelson et al.,  1986; 
Verheijen et al., 1988; see also Fey et al., 1986). Chromatin 
is organized  in loops anchored to the scaffold  at  specific 
DNA regions (reviewed by Gasser and Laemmli, 1987), and 
heterogeneous ribonucleoproteins (HnRNPs) also appear to 
be connected with this structure (see Fey et al.,  1986). Be- 
cause of these associations,  it has been proposed that  the 
scaffold is not a simple structural  element but a dynamic en- 
tity involved in DNA replication,  transcription,  pre-mRNA 
processing, and mRNA transport.  These processes could oc- 
cur at a solid state/solution  interphase,  and the latter  three 
might be topologically and temporally linked (see Nelson et 
al., 1986; Cook, 1988). Consistent with part of this general 
hypothesis are data suggesting an involvement of the nucleo- 
1. Abbreviations used in this paper: HnRNP, heterogeneous nuclear ribonu- 
cleoprotein; HS-NM, nuclear matrix prepared by extraction with high-salt; 
LS-NM, nuclear matrix prepared by extraction with low-salt; NM, nuclear 
matrix preparation; PVA, polyvinyl alcohol; SCF, splicing complementing 
factor;  snRNP, small nuclear ribonucleoprotein. 
skeleton in DNA replication and transcription (see, for exam- 
ple, Jackson and Cook, 1985, 1986). In addition,  a temporal 
linkage between transcription  and processing is supported by 
electron microscopic analyses indicating that splicing occurs 
cotranscriptionally  in a subset of nascent precursors  (Osheim 
et al.,  1986; Beyer and Osheim,  1988). 
In vitro experiments  (reviewed  by Padgett et al.,  1986; 
Green, 1986; Sharp, 1987; Krainer and Maniatis,  1988) have 
demonstrated that  splicing  can occur in solution  after the 
assembly of a  multicomponent complex, the spliceosome 
(Brody and Abelson, 1985; Grabowski et al., 1985; Frende- 
way and Keller, 1985). Thus, under in vitro conditions,  bind- 
ing of spliceosomes to a solid support is not a prerequisite 
for their function.  However, in the absence of any evidence 
for the existence of free nucleoplasmic splicing complexes, 
direct extrapolations  to the in vivo situation  are not war- 
ranted. 
In situ pre-mRNA splicing might be occurring in matrix- 
bound spliceosomes,  representing  at least a  subset of the 
HnRNPs.  Anchorage  of spliceosomes to a  solid  structure 
could be advantageous for rapid and efficient splicing and/or 
coupling  of pre-mRNA processing and mRNA transport. 
However,  such  a  hypothesis  lacks  experimental  support. 
Moreover, variability in results and the possibility of artifacts 
hamper the interpretation  of data obtained with the matrix. 
In this regard,  it is important  to make a distinction  between 
the presumptive "in situ nuclear matrix"  and a biochemical 
"nuclear matrix preparation" (NM). The latter can be defined 
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detergent  extraction  of interphase  nuclei  that  have  been 
treated with DNase I (see Bouteille et al.,  1983; Berezney, 
1984; Nelson et al.,  1986; Verheijen et al.,  1988).  In such 
preparations the HnRNPs partition with the pellet, whereas 
they can be isolated from nuclei or from NM as free particles 
only by sonication. Nevertheless, arguments have been made 
that such complexes are found associated with the NM be- 
cause of artifactual aggregation and precipitation in high salt 
of RNA and soluble proteins onto a subnuclear fraction (for 
discussion, see Bouteille et al.,  1983;  Berezney, 1984). 
Because of  these problems, we decided to examine the pos- 
sible association of the splicing apparatus with the NM by 
applying a functional criterion. For this purpose, we devel- 
oped a system that can be used to assay splicing events occur- 
ring in NM preparations under defined in vitro conditions 
(Zeitlin et al., 1987; see also Results). In such assays a NM 
pellet isolated after a 0.4 M KCI wash, was incubated in the 
presence of ATP and Mg  2+ with a HeLa cell in vitro splic- 
ing extract (Dignam et al., 1983; Krainer et al., 1984).  We 
observed that the amount of a matrix-associated specific pre- 
mRNA progressively decreased without a  significant tem- 
poral lag, with a corresponding increase in free intron lariat 
(Zeitlin et al., 1987). From these results, we postulated that 
parts of  preassembled splicing complexes had survived in the 
NM preparation and could be complemented for splicing 
with soluble factors in the extract. However, our data did not 
exclude the possibility that the functional (complementable) 
structures were localized in the NM pellet simply as a conse- 
quence of the method of preparation. 
Here we show that if the high-salt extraction in the NM 
preparation protocol is substituted with a 0.1 M KC1 wash (an 
approximately physiological concentration of monovalent 
cation), splicing of pre-mRNA occurs in the matrix pellet 
under in vitro conditions in the absence of  added extract ("au- 
tonomous splicing"). This suggests that the precursor in the 
preparation is associated with all of the spliceosome compo- 
nents.  In addition, we report studies on complementation 
reactions of preassembled,  but  not autonomous,  splicing 
complexes with splicing extract, and define conditions under 
which the first and second splicing steps can be uncoupled. 
Finally, we describe some biochemical features of the com- 
plementing activities and their  relationship to previously 
identified splicing factors other than small nuclear ribonu- 
cleoproteins (snRNPs). 
Materials and Methods 
Matrix Preparation 
Our transfection/infection protocol (see Results), the plasmid construction 
ptkR2 used for transfection of HeLa cells, and the probes used for RNA 
blot hybridization, have been described previously (Zeitlin et al.,  1987). 
Nuclear matrix was prepared as described (Gallinaro et al.,  1983;  Zeitlin 
et al., 1987) with the following modifications. After digestion of the nuclei 
with DNase I and centrifugation for 15 rain at 600 g through a 30% sucrose 
cushion containing 10 mM Tris-HCl, pH 7.4, 0.1 M KCI, 0.2 mM MgC12, 
1 mM DTT,  and 1 mM PMSF, the matrix pellet was resuspended gently 
in ",,10 vol of buffer D (20 mM Hepes, pH 7.9, 0.1 M KCI, 0.2 mM EDTA, 
1 mM DTT,  1 mM PMSF, and 20%  [vol/vol]  glycerol; Dignam et al., 
1983),  and repelleted (10 min centrifugation). This low salt-matrix (LS- 
NM) was then resuspended in a  small volume of buffer D  ('x,105 nuclei 
equivalents per microliter) and divided into small aliquots that were quickly 
frozen in liquid N2 and stored at  -80"C. These preparations were stable 
for 1-2 mo. Freezing and thawing once or twice had no noticeable effect 
on autonomous splicing or complementation assays. For the preparation of 
derivative high-salt matrix (HS-NM),  10--20/~1 aliquots of LS-NM were 
thawed on ice and, after the addition of 400 tA of high-salt wash buffer (10 
mM Tris, pH 7.4, 0.6 M KCI, 1.5 mM MgCI2, 1 mM DTT,  1 mM PMSE 
and 0.25  M  sucrose), incubated on ice for 15 rain. The matrix was then 
pelleted by a 15-s spin in a microfuge at 4"C, washed with 200 ~1 of buffer 
D,  repelleted, and finally resuspended in the original matrix volume of 
buffer D. 
Extract Preparation 
HeLa cell nuclear extract and S100 cytoplasmic fraction were prepared ex- 
actly as described by Dignam et al. (1983).  The same procedure was used 
for sequential extraction of crude nuclei with increasing concentrations of 
KCi,  as follows. Crude nuclei were resuspended in buffer C  containing 
0.1 M KCI (20 mM Hepes, pH 7.9, 0.1 M KCI,  1.5 mM MgCI2,  0.2 mM 
EDTA, 1 mM DTT,  1 mM PMSF, and 25% glycerol; •3  x  109 nuclei/ml) 
and stirred for 30 rain at 4"C. After pelleting for 20 min at 25,000  g, the 
supernatant (0.1 M extract) was collected, and the nuclei were extracted se- 
quentially by repeating the procedure with equal volumes of the same buffer 
containing KCI at final concentrations of 0.2, 0.3, 0.4, 0.5, and 0.6 M. All 
extracts were then dialyzed against buffer D and stored in small aliquots. 
To eliminate snRNPs by ultracentrifugation (Ruskin et al.,  1988),  NP-40 
at a final concentration of 2 % was added to the extract, which was then cen- 
trifuged for 2 h at ~360,000 g in an ultracentrifuge  (model TL-100; Beckman 
Instruments Inc., Palo Alto, CA) using the TL100.2  rotor.  (NP-40 at a final 
concentration of 1.2%  does not affect matrix complementation assays.) 
Complementation Reactions 
A typical complementation reaction (25 #1) contained 80 mM KCI, 0.5 mM 
MgCI2,  1.5 mM ATE 5 mM creatine phosphate, 1 mM DTT, 20 U placen- 
tal  RNase inhibitor (RNasin;  Promega Biotech, Madison, WI),  2  #1 of 
derivative HS-MX (,v2  x  l0  s nuclei equivalents), and 60%  (vol/vol) of 
HeLa cell nuclear extract or S100 (15 td). Buffer was supplied by the extract 
(12 mM final concentration of Hepes, pH 7.9).  Polyvinyl alcohol (PVA) at 
a final concentration of 0.9% was included in some assays. In some experi- 
ments (see text) we used extract that had been desalted by gel filtration on 
a Sephadex G-25 column (300 #1 of extract per prepacked NAP-5 column; 
Pharmacia Fine Chemicals, Piscataway, NJ) equilibrated with a buffer con- 
taining 25 mM triethann!~,,~;~:  ,~etate, pH 7.9, and 0.1 M KC1. Reactions 
were incubated at 30ct.: for various times as indicated in figure legends. The 
samples were depmteinized using proteinase K (Boehringer Marmheim Bio- 
chemicals, Indianapolis, IN) in the presence of SDS, as described (Krainer 
et al.,  1984),  and, after phenol extraction, the RNA was ethanol precipi- 
tated. For better electrophoretic resolution, the RNA was deadenylated for 
20 min at 30°C in a 25/zl reaction containing 50 mM Tris, pH 7.4, 50 mM 
KCI, 1 mM MgC12, 0.5 mM DTT, 200 U/ml RNasin, 10 #g/ml oligo(dT)ts, 
and 8 U/ml Escherichia coli RNase H (Pharmacia Fine Chemicals). After 
treatment with RNase-free DNase I (10 #g/ml) for 10 rain at 300C, phenol 
extraction, and ethanol precipitation, the RNA was subjected to electropho- 
resis on denaturing 5%  urea-polyacrylamide gels and  transferred elec- 
trophoretically onto nylon membranes (GeneScreen Plus; New England 
Nuclear, Boston, MA). Prehybridization and hybridization with high spe- 
cific activity single-stranded probes synthesized on MI3 templates (Hu and 
Messing, 1982)  were as described (Zeitlin and Efstratiadis, 1984). 
Autonomous Splicing Reactions 
For  autonomous  splicing,  the  complementation reaction conditions de- 
scribed above were modified; the matrix was not washed, extract was sub- 
stituted with buffer D, and PVA was omitted. To define optimal conditions 
promoting autonomous splicing, we tested various reaction parameters (data 
not shown). 
ATP at concentrations of 0.5,  1.5, 2.0, or 5.0 raM, and Mg  2÷ at concen- 
trations of 0.5,  1.0, 2.0, or 4.0 mM, were tested in all combinations. We ob- 
served that under all of these conditions the efficiency of autonomous splic- 
ing was invariant (data not shown). Although we did not examine ATP 
concentrations below 0.5  mM,  we performed a  finer titration for Mg  2+ 
(using ATP at a fixed concentration of 1.5 mM; see text). 
The autonomous splicing reaction exhibited a very broad optimum of 
KC1 concentration between 40 and 150 mM; 80% of  the maximal efficiency 
at 0.1 M was obtained at any concentration in this range. The reaction could 
still be sustained (at ,x,50 % of the maximal efficiency) at concentrations be- 
tween 8 and 20 mM, whereas concentrations of KCl >200 mM were inhibi- 
tory.  We note that  complementation reactions of HS-NM  with  nuclear 
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mRNA (A) Northern analysis of total RNA extracted from aliquots 
(2/~l per lane) of a low-salt nuclear matrix preparation (0.1  M  KCI 
final wash). The matrix was prepared from HeLa cells that had been 
transfected with plasmid ptkR2. The insert of this plasmid is a frag- 
ment of the rabbit/3 globin gene that includes the second interven- 
ing sequence (see Results and Materials and Methods). In this and 
in subsequent experiments the blots were hybridized with a rabbit 
/3 globin IVS2 probe. The RNA was extracted either directly (time 
zero control, to;  lane 1) or after incubation of the matrix for 30 
min at 30°C in splicing buffer, in the presence (+) or absence (-) 
of ATP and Mg  2+ in all combinations (lanes 2-5). Creatine phos- 
phate (CP) was omitted from the reaction of lane 6. The hybridizing 
bands, corresponding to the precursor (P), the lariat-exon2 inter- 
mediate (LE2), and the free lariat product (L), are indicated in this 
and in subsequent figures. (B) The Northern profile of RNA (lane 
1 ) from a reaction identical to that in lane 4 A, but from an indepen- 
dent experiment, and the corresponding time zero control (lane 2). 
extract exhibited similar requirements for monovalent cation. KCI concen- 
trations as low as 14 mM could still sustain complementation. 
The pH optimum was also very broad. Autonomous splicing efliciencies 
were  practically  invariable throughout a  pH  range between 6.5  and 7.9. 
However, only 25% of this level was attained at pH 8.5. The reaction was 
rapid at the three temperatures that we examined (20, 30, and 37°C).  How- 
ever, reactions at 37"C longer than 10 min resulted  in RNA degradation. 
Substitution of Hepes-KOH  with triethanolamine-acetate buffer  had  no 
effect on the reaction. 
DEAE-Sepharose Chromatography 
Nuclear extract was fractionated on DEAE-Sepharose as described 0Q2mer 
et al., 1987). A 7-rnl DEAE-Sepharose column (Fast Flow; Pharmacia Fine 
Chemicals) was equilibrated with 10-column volumes of buffer containing 
0.1 M KCI, 20 mM Hepes-KOH,  pH 7.9, 0.1 mM EDTA, 3 mM MgCI2, 
0.5 mM DTT, 0.5 mM PMSE and 10% glycerol.  Nuclear extract (22 mg 
protein, adjusted to a concentration of 4 mg/ml with buffer D) was applied 
to the column at a flow rate of 2 ml/min. The flowthrough (20 ml) was col- 
lected,  and the bound protein was eluted with 20 ml of equilibration buffer 
containing 0.5  M  KCI. Fractions were  frozen  in liquid N2 and stored  at 
-80°C.  For matrix complementation assays,  aliquots of the two fractions 
were concentrated by ammonium sulfate precipitation  (0.6 g/ml fraction). 
The  precipitate  was  collected  by  centrifugation  (20,000  g,  30  min), 
resuspended in a small volume of buffer D, and desalted on a NAP-5 column 
equilibrated with buffer D. The flowthrough and bound fractions were con- 
centrated "~7.5- and 5.5-fold, respectively  (the corresponding final concen- 
trations of protein were 4.6 and 7.1 mg/ml). Protein concentrations were de- 
termined according to Bradford  (1976). 
Binding of SCF to the Matrix 
We performed two types of experiments in which complementing factors in 
the nuclear extract were bound to the matrix. In the first type, matrix and 
extract were incubated in the presence of Mg  2+ at low concentration, and 
then the matrix was purified away from the extract by centrifugation  through 
Figure 2. Kinetics of autonomous splicing. The corrected percent- 
age of released intron lariat at each time point (calculated as de- 
scribed in Materials and Methods) is plotted in A.  The results of 
four independent experiments using different low-salt matrix prepa- 
rations incubated in splicing buffer without extract are shown. Also 
shown are the results from a single experiment using whole hypo- 
tonic  nuclei  instead of matrix.  The arrow  indicates the time re- 
quired for half-completion of the reaction ('~5 min) calculated from 
this graph. An example of the Northern analyses used to derive the 
plotted data (matrix experiment 4) is shown in B. 
a sucrose cushion, and incubated under conditions of autonomous  splicing 
("cushion experiment").  In the second type of experiment, the extract and 
the matrix were not separated after the first incubation, but the reaction vol- 
ume was increased  ("dilution experiment"). 
The first reaction of the "cushion experiment" (100/~i) contained 1.5 mM 
ATE 5 mM creatine phosphate,  50/~M MgCI2,  1 mM DTT, 400 U/ml 
RNasin, 80 mM KCI, 20 mM Hepes,  pH 7.9, 13 mM triethanolamine, pH 
8.3, 0.9%  PVA, 55%  (vol/vol) of desalted  extract,  and 15/zl of HS-NM 
(prewashed with 0.6 M KCI). After 30 rain at 30"C, the reaction was layered 
on a 100-#1  cushion in an Eppendorf  tube, containing 30% (wt/vol) sucrose, 
50/~M MgCI2, 1 mM DTT,  12 mM each Hepes and triethanolamine, and 
0.9% PVA, and centrifuged  for 15 rain in a micrefuge (12,000 g). The ma- 
trix pellet was resuspended in 10/~1 of cushion buffer without sucrose.  A 
3-/~1 aliquot was then incubated in a 25-t~1 reaction as described above, ex- 
cept that extract was omitted and the Mg  2+ concentration was raised to 0.5 
mM. A second equal aliquot was incubated as above, but without ATP and 
creatine phosphate,  whereas a third aliquot (control) was deproteinized  im- 
mediately. 
The first reaction of the "dilution experiment  ~ was the same as that of the 
"cushion  experiment", except that it was performed in a volume of 25 t~l con- 
taining 4 td HS-MX and no PVA. To provide controls, an additional mock 
reaction was performed by omitting the desalted extract. After withdrawing 
(from the reaction or the mock reaction)  half of the volume for immediate 
deproteinization,  the other half  was diluted by adding 1 ml buffer containing 
all of the ingredients  of the first reaction, except that the concentration of 
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30"C without any additions in the experimental reaction, whereas 6.75 #1 
of desalted extract were added to the diluted mock reaction. 
In Vitro Splicing 
SP6 transcription and splicing reactions were performed as described (Par- 
ent et al.,  1987). The plasmid construct used to derive the SP6 precursor 
contains the first exon, the IVS1, and portion of the second exon of the rabbit 
/3 globin gene (construct WT; Parent et al.,  1987). 
Densitometric Scanning 
Northern blots were autoradiographed using XAR-5 film (Eastman Kodak 
Co., Rochester, NY) at -80°C with an intensifying screen for 2-16 h. Ex- 
posures within the linear response range of the film were scanned with the 
Joyce-Loebl Chromoscan-3 densitometer, and the areas under the peaks (in- 
tensities) were calculated for the precursor (P), the lariat-exon2 (LE2), the 
free lariat (L), and (whenever it appeared) the nicked-lariat (Y). For each 
reaction (or time point), we considered the sum U +  Y =  L as the intensity 
value for "lariat",  and the sum L  +  P  +  LE2 =  S as the total intensity. The 
calculated percentages of each species were %L =  (L/S)  ×  100,  %LE2 = 
(LE2/S)  ×  100, and %P  =  (P/S)  ×  100. We call the %L and %P values 
of the zero time controls of autonomous reactions %L0 and %P0,  respec- 
tively,  and the corresponding values of the "autonomous splicing back- 
ground" of complementation reactions  %La and  %Pa,  respectively. The 
corrected  %L values, plotted in Figs. 2  and 4,  were the ratios  %~or~  = 
(%L  -  %Lo)/%P0 and  %~orr  =  (%L  -  %La)/%Pa,  respectively. 
Results 
In Vitro Splicing Assays of  Matrix-associated 
Pre-mRNA 
For splicing assays, we use the following system. A plasmid 
(ptkR2; Zeitlin et al.,  1987)  is first transfected into HeLa 
cells. This construct contains the inducible promoter of the 
herpes simplex virus tk gene linked to a segment of  the rabbit 
/3 globin gene that includes the second intervening sequence 
flanked by two exons. After transfection, the promoter is 
transactivated by infecting the cells with a tk- herpes sim- 
plex virus. Nuclear matrix is then prepared from the trans- 
fected/infected HeLa cells, and used for splicing assays un- 
der in vitro conditions. The pre-mRNA transcript and its 
splicing intermediates and products can be monitored by 
high resolution Northern analysis, using an IVS2 probe or 
an exonl probe. The IVS2 probe detects the pre-mRNA, the 
lariat-exon2 intermediate, and the free intron lariat. Linear 
intron (debranched lariat) and nicked lariat (an artifact of the 
in vitro manipulation of the RNA) are occasionally also de- 
tected.  The exonl  probe detects pre-mRNA,  exonl  inter- 
mediate, and mature mRNA. The majority of these RNAs 
(80-99 %, depending on the species) are associated with the 
matrix pellet after a 0.4 M KC1 wash. In this pellet, the ma- 
ture mRNA is ,,o20-fold more abundant than the precursor 
(Zeitlin et al.,  1987).  Thus,  ligation of exons cannot be 
monitored in our assay system because even complete con- 
version of the pre-mRNA to spliced product would result in 
only a small increase in the amount of preexisting mRNA. 
For this reason, we measure in our assays the decrease in the 
level of precursor, the corresponding increase of free intron 
lariat, and any change in the level of lariat-exon2 intermedi- 
ate.  The assay monitors three splicing reactions; endonu- 
cleolytic cleavage at the 5' splice site and intron branching 
(first splicing step), and cleavage at the 3' splice site (one of 
the reactions of the second step).  We assume that the fourth 
reaction (ligation of exons) is also occurring, since it is con- 
comitant with the release of intron lariat (reviewed by Padgett 
et al.,  1986;  Green,  1986;  Krainer and Maniatis, 1988). 
Autonomous Splicing in Matrix-associated Complexes 
Previously, we defined as matrix preparation the insoluble 
pellet that was obtained after a final 0.4 M KCI wash (HS- 
NM; Zeitlin et al., 1987).  During complementation experi- 
ments using such pellets, we observed that the control re- 
actions of some preparations (HS-NM incubated in buffer 
containing ATP and Mg  2+, but no extract) exhibited very 
low levels  of splicing. We call this reaction "autonomous 
splicing" to indicate that it occurs in fully assembled and 
functionally self-sufficient complexes. 
To examine in detail the splicing of NM-associated pre- 
mRNA in preparations extracted with different salt concen- 
trations, we first prepared NM using for the final wash a 
buffer containing 0.1 M KC1 (LS-NM). This is the approxi- 
mate physiological concentration of K  +,  the main nucleo- 
plasmic cation (Palmer and Civan, 1975, 1977; reviewed by 
Civan,  1978; see also Alvarez-I_e.efmans,  1986). 
An aliquot of the LS-NM was immediately deproteinized 
to serve as a time zero negative control (Fig.  1 A, lane 1). 
Equal portions of  the LS-NM were then incubated for 30 min 
at 30°C in the presence of splicing buffer alone (final KC1 
concentration of 80 mM; lane 2), in buffer containing 1 mM 
Mg  z+ (lane 3), in buffer containing 1.5 mM ATP (lane 4), 
or in buffer containing both ATP and Mg  2+ (lane 5).  The 
concentrations of KC1, ATP, and Mg  2+ were chosen on the 
basis of previous complementation assays with nuclear ex- 
tracts. 
We observed that only when both ATP and Mg  2÷ were 
present (Fig. 1 A, lane 5; compare with lanes 2-4), the struc- 
tures associated with the LS-NM were capable of  autonomous 
splicing according to our criterion (decrease of pre-mRNA 
with corresponding increase of free lariat, as compared with 
the time zero control; compare lanes 1 and 5 in Fig.  1 A). 
Omission of creatine phosphate from the complete reaction 
did not change the result (Fig. 1 A, lane 6). In the reaction 
that was performed in the presence of  ATP, but in the absence 
of Mg  ~÷ (lane 4),  we observed some degradation of both 
the lariat-exon2 and the free lariat species, for unknown rea- 
sons. However, this result was not consistent (Fig. 1 B, lane 
1; compare with lane 2). By varying the parameters of the 
reaction,  we  defined optimal  conditions for  autonomous 
splicing (see Materials and Methods). 
Autonomous splicing complexes assembled in vitro on 
SP6  precursors  have not been  identified yet, despite  the 
description of several  forms  of complementable spliceo- 
somes (Grabowski et al., 1985; Lin et al., 1987; Cheng and 
Abelson,  1987; Reed et al.,  1988;  Abmayr et al.,  1988). 
Thus, it could not be excluded that the splicing reactions de- 
pend on triggering by transiently associated factors. Such a 
hypothesis can now be eliminated. 
Study of the kinetics of autonomous splicing (Fig. 2) indi- 
cated that the reaction is rapid and does not exhibit a tem- 
poral lag (in contrast to in vitro splicing reactions or matrix 
complementation; see below). An increase in free lariat was 
detected even at the earliest time point that we examined (1 
min; Fig. 2 B), and the reaction was half-complete in ~5 
min (Fig. 2 A). These features provide additional evidence 
supporting our interpretation that the autonomous splicing 
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complexes. The Northern blots in A and B were hybrid- 
ized with an IVS2 probe. The blot in A' is the same as 
in A after rehybridization with an exonl probe without in- 
termediate washing. It is shown as an example demon- 
strating the abundance and practically constant amount of 
mature mRNA (M). E1 is the first exon. For these experi- 
ments, low-salt matrix (0.1 M KCI wash) was prepared, 
and aliquots were washed again either with 0.1 M KCI 
or with higher KCI concentrations, as indicated. (The 
results from a 0.4 M KCI wash were practically identical 
to those obtained with the 0.5 wash, but are not presented 
because of low RNA recoveries.) RNA extracted directly 
from a portion of  each washed aliquot (time zero negative 
controls; to) is displayed in lanes 1, 4, 7, 10, and 13. Two 
other portions from each washed aliquot were incubated 
for 30 rain at 30°C either in splicing buffer alone (D; 
lanes 2, 5, 8, 11, and 14) or in buffer containing nuclear 
extract  (E;  lanes 3,  6,  9,  12,  and 15). 
reactions occur in preassembled complexes that require for 
function only ATP and Mg  2+. 
We note that the time course of  the splicing reaction, moni- 
tored in whole hypotonic nuclei (washed with 0.1 M KCI), 
was indistinguishable from that occurring in LS-NM prepa- 
rations (Fig. 2 A). This result can be minimally interpreted 
as indicating that the destruction of chromatin structure by 
DNase I to derive the matrix preparation does not perturb 
the splicing complexes. Variation in the nuclei isolation pro- 
cedure did not affect (positively or negatively) autonomous 
splicing; the behavior of LS-NM prepared from nuclei that 
were obtained from isotonically lysed cells was identical to 
that derived from hypotonic nuclei (not shown). We also note 
that  the  matrix-associated  splicing  complexes  cannot  be 
solubilized in functional form under a variety of conditions 
that we have used (unpublished results). Complexes could be 
released from the matrix by sonication or by incubation at 
30°C in very low salt (<5 raM), but they were incompetent 
for splicing either in autonomous reactions or in comple- 
mentation  assays.  A  drastic  solubilization  protocol using 
lithium diiodosalycilate (Mirkovitch et al.,  1984) also re- 
leased nonfunctional complexes from the matrix, containing 
only U2 and U5 snRNAs. 
Our results indicate that the function of the apparently in- 
soluble splicing complexes is not affected by potential ex- 
perimental artifacts due to hypotonic lysis conditions, DNase 
I digestion, and high-salt effects during matrix preparation. 
However, a crucial question remains open: does autonomous 
splicing occur in complexes that are artifactually associated 
with the matrix preparation? To invoke artifacts, one has to 
suggest that the functional splicing complexes we study are 
in  reality  soluble  nucleoplasmic  entities,  which,  for un- 
known reasons, partition with the pellet during fractionation 
even under physiological concentrations of monovalent cat- 
ion.  We consider this  an unlikely possibility because we 
cannot identify any plausible  cause  for such hypothetical 
behavior of  the complexes. Nevertheless, further experimen- 
tation is necessary to resolve this issue. 
Complementable  Splicing Complexes 
To examine the salt resistance of the autonomous splicing 
complexes, we washed equal portions of a LS-NM prepara- 
tion with buffer containing KC1 in concentrations ranging be- 
tween 0.4 and 1.0 M, and then divided each sample into three 
equal aliquots.  One of them was deproteinized (zero time 
control), a second was incubated under conditions of  autono- 
mous splicing, and the third was complemented with extract 
(Fig.  3).  All of the washed samples were incapable of au- 
tonomous splicing.  However, the leftover structures could 
still be complemented for splicing, regardless of the concen- 
tration of salt used for washing (Fig. 3, A and B, lanes 4-15). 
We infer from these data that one or more splicing factors 
are removed by washing with KC1 at concentrations >0.4 M. 
These components can be added back to functional com- 
plexes by complementation with extract. For simplicity, we 
call the complementing activity or activities SCF ("splicing 
complementing factor"). 
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percentage of released intron lariat at each time point of a com- 
plementation reaction is plotted in A. The results are from three in- 
dependent experiments using different matrix preparations washed 
with 0.6 M KCI and then complemented for splicing with nuclear 
extract. Because of clustering, it is not possible to discriminate in 
the graph that the lag period (0% lariat) is represented by six points 
(assays at 1, 2, and 3 min from two experiments). An example of 
the Northern analyses used to derive the plotted data (experiment 
3) is shown in B. To provide a negative control, an aliquot of matrix 
was incubated for 60 min at 30°C in buffer alone (B, lane D).  Y 
is the nicked-lariat species. 
These results indicated that we could generate from a sin- 
gle,  autonomously splicing,  LS-NM preparation a  second 
form of complementable HS-NM by washing  with 0.6  M 
KCI. This treatment guarantees that the autonomous splic- 
ing,  which  is  occasionally  observed  with  some  HS-NM 
preparations (and constitutes "background" for complemen- 
tation reactions) can be effectively eliminated. 
We used such derivative HS-NM to study the kinetics of 
complementation reactions. In contrast to the kinetics of au- 
tonomous splicing, complementation kinetics can vary be- 
tween reactions. It is expected, for example, that the com- 
plementation kinetics with a  fixed amount of matrix will 
change upon dilution or concentration of extract. In our par- 
ticular examples (Fig. 4), the reactions exhibited a brief tem- 
poral lag of"o5 min (Fig. 4 A), apparently reflecting the time 
necessary for association of complementing factors. The in 
vitro splicing reactions with SP6 precursors usually exhibit 
a 30-min lag for the detection of splicing products (reviewed 
by Padgett et al., 1986; Green, 1986; Krainer and Maniatis, 
1988), presumably corresponding to the time required for 
complete assembly. 
Our complementation reactions did not reach completion; 
,x,65 % of  the precursor was converted into product in 90 rain 
(Fig. 4 A). We found it difficult to determine the exact time 
at which  such reactions reach a  plateau because of RNA 
degradation during prolonged incubations with unfraction- 
ated or undiluted extracts. However, on one occasion, when 
the RNA was left intact after 2 h of incubation, we observed 
that ,,086%  of the precursor was converted into free lariat. 
This result suggests that only a small minority of complexes, 
if any,  are irreversibly damaged (for example, rearranged) 
during the matrix preparation procedure, including second- 
ary washing with high salt. 
Parallel  examination  of autonomous  splicing  and  com- 
plementation using  the  same  LS-NM  preparation  showed 
that the level of splicing attained in the autonomous reaction 
was  augmented by addition of nuclear  extract (Fig.  3  A, 
compare lane 2 with lane 3). Quantitation by densitometry 
showed that ,'-25 % of the precursor was converted to product 
during  autonomous  splicing,  whereas  an  additional  40% 
could be spliced after complementation for 30 min.  These 
numbers varied only slightly in repeats of such assays using 
different  preparations incubated for the same amount of  time. 
Although more precursor is chased into product in longer in- 
cubations (see above, and Fig. 4), autonomous splicing does 
not exceed 25 %. Since complementable complexes are also 
present in the matrix, a corollary of this result is that SCF 
does not recycle under in vitro conditions, although such a 
possibility cannot be excluded for the in vivo situation. The 
absence of recycling is consistent with the results of mixing 
experiments (not shown); addition of excess nonspecific LS- 
NM (prepared from HeLa cells without transfection/infec- 
tion) did not complement for splicing HS-NM from trans- 
fected/infected cells. 
Uncoupling of the First and Second Splicing Steps 
While testing the variables of the matrix complementation 
reaction, we identified two conditions under which splicing 
can be reversibly arrested after the first step, as evidenced 
by the accumulation of lariat-exon2 intermediate. 
Uncoupling by Extract Dilution. Our transfection/infec- 
tion protocol includes treatment of the cells with cyclohexi- 
mide. Interestingly, this protein synthesis inhibitor does not 
impair splicing, even when the treatment is extended for as 
long as 6 h (Zeitlin et al., 1987). This observation is consis- 
tent  with  the  existence  of  a  significant  factor  reservoir 
(and/or with vigorous in vivo recycling of splicing compo- 
nents). Thus, we thought that SCF must be present in a large 
excess in the amount of extract (15-30 #1) used in our stan- 
dard reactions to complement an aliquot of HS-NM (2/~1); 
these  amounts  correspond  to  5  x  106-107 and  2  x  105 
nuclei equivalents,  respectively (assuming,  for illustration 
purposes,  that there are  no losses  during  the preparation 
procedures). 
To examine directly the validity of these estimates, we per- 
formed a titration experiment (Fig. 5 A) using a fixed amount 
of matrix (2 #1/50 #l reaction) and extract that was either un- 
diluted  (0.6  #l/#l  of reaction) or  serially diluted.  We ob- 
served that the amount of released free lariat was progres- 
sively  reduced  (Fig.  5  A,  lanes  3-5),  and  practically 
abolished when the extract was diluted eightfold (lane 6). In 
two  additional  experiments,  that  were  performed  using 
different preparations of matrix and extract, free lariat still 
The Journal of Cell Biology, Volume  108, 1989  770 Figure  5.  (A)  Complementation  reactions 
with diluted nuclear extract or Sl00 cytoplas- 
mic fraction.  A nuclear  matrix preparation 
was washed with 0.6 M KCI and divided into 
2-#1 aliquots.  RNA  was extracted  immedi- 
ately from an aliquot for display (time zero 
control;  lane  1).  A  second aliquot  was in- 
cubated under splicing conditions in buffer D, 
but without extract for 60 min at 30°C (con- 
trol to demonstrate  that the salt wash effec- 
tively eliminated autonomous  splicing; lane 
2). Other aliquots were complemented in 50- 
#1 reactions with 30 #1 of nuclear extract, ei- 
ther undiluted (lane 3) or diluted with buffer 
D, twofold (lane 4), fourfold (lane 5), or eightfold (lane 6). Complementation reactions using S100 fraction (instead of extract),  either 
undiluted or twofold diluted resulted in RNA degradation  (lanes  7 and 8, respectively).  The results of complementation reactions with 
fourfold or eightfold diluted S100 fraction are shown in lanes 9 and 10, respectively. (B) Complementation reactions with increasing amounts 
of matrix.  The same matrix and nuclear extract preparations  as in A were used in 25-#1 complementation reactions, each containing 7.5 
#1 of extract and increasing amounts of matrix (0.5, 1.0, 2.0, or 4.0 #1; lanes 3, 4, 5, and 6, respectively).  The controls  in lanes 1 and 
2 (RNA from 1 #1 of matrix per lane) correspond  to those in the same lanes of A. 
appeared, despite its progressive decline, even after a 16-fold 
dilution of the extract (data not shown). These results appar- 
ently reflect the relative concentrations of factors in different 
extracts.  We assume that during  the fixed incubation time 
(1 h) the number of fruitful collisions (leading to association) 
between the SCF and a stationary constant number of com- 
plementable complexes on the matrix is reduced because of 
the dilution. 
Unexpectedly, in all of these experiments we observed ac- 
cumulation of the lariat-exon2 intermediate when the dilu- 
tion of extract was fourfold or higher (see Fig. 5 A, lanes 5 
and  6).  Additional experiments (not shown)  indicated that 
the uncoupling of the two splicing steps upon extract dilution 
is a  kinetic phenomenon; the second step also appeared in 
the presence of eightfold diluted extract by extending the in- 
cubation time beyond 2  h. 
To examine whether uncoupling is due to a requirement for 
a  limited component, we performed an additional titration 
experiment. This time we used in all of the reactions (25/zl 
each) a  twofold dilution  of extract (0.3/~1//~1 of reaction), 
while increasing stepwise the amount of matrix between 0.5 
and 4.0 #1. We observed that the extract was always in excess, 
and that accumulation of intermediate did not occur (Fig. 5 
B, lanes 3-6); in all four reactions, constant percentages of 
tariat-exon2 and free lariat were detected by densitometry, 
which, in absolute amounts, were exactly proportional to the 
matrix  input  in  each reaction.  Excess of factors was also 
demonstrated in an independent experiment (not shown) in 
which  increasing  amounts  of  nonspecific  HS-NM  were 
added  to  the  same amount  (2  /~1) of HS-NM  from trans- 
fected/infected cells. Competition for complementing factors 
present in the extract (0.3 #1//~1 of reaction volume) was not 
observed even at  a  ratio of nonspecific/specific matrix of 
15:1. 
Biochemical Uncoupling. Uncoupling of the two splicing 
steps was also observed under the following conditions. The 
splicing extract was first desalted by gel filtration to remove 
free  Mg  2÷,  and  then used  in  a  series of complementation 
reactions  with  HS-NM,  performed under  standard  condi- 
tions,  but  with  Mg  2÷  added  at  varying concentrations.  A 
small  increase  of  lariat-exon2  was  observed  even  when 
Mg  2÷ was not added to the reaction (Fig.  6 A/, lane 2,  and 
Fig. 6 A2, lane 3).  However, detection of this first splicing 
step was abolished by addition of EDTA (Fig. 6 A2, lane 4). 
Thus, it seems that after desalting of the extract some tightly 
bound Mg  2÷ is left behind that can propagate to some extent 
the first splicing step in the presence of ATP (Fig. 6 A2; com- 
pare lane 2  with lane 3). 
The amount of lariat-exon2 intermediate increased  with 
increasing Mg  2÷ concentration, and reached a plateau at 50 
/~M Mg  2÷, with the simultaneous appearance of some free 
lariat product (Fig. 6 A/, lane 4). The ratio of intermediate 
to  product  decreased  progressively with  increasing  Mg  2÷ 
concentrations above the 50-#M level (Fig. 6 A/, lanes 5-8). 
When the Mg  2÷ concentration exceeded 200 #M,  accumu- 
lation of the intermediate was no longer detectable (Fig.  6 
A/,  lanes 9-11). 
It is noteworthy that the autonomous complexes, which al- 
ready contain SCF, behave differently than the complement- 
able complexes in reactions with increasing Mg  2÷ concen- 
trations.  In a series of autonomous reactions of LS-NM we 
used  1.5  mM  ATP  and  Mg  2÷  concentrations  varying  be- 
tween 5 #M and 1 mM. The lariat product was barely detect- 
able, if at all, at Mg  2÷ concentrations below 50 #M (Fig. 6 
B, lanes 2-5), whereas at an apparent threshold of 100/~M 
Mg  2÷ the reaction reached its maximal attainable efficiency 
(lane 6; compare with lanes 7 and 8).  However, accumula- 
tion of lariat-exon2 was not observed in any of these reac- 
tions. 
Binding of  SCF to Complementable Spliceosomes 
The  identification  of biochemical  conditions  to  uncouple 
reversibly the two splicing steps suggested the following ex- 
periment to "pick-up" SCF from the extract by affinity. 
Matrix was washed with 0.6  M  KCI, and an aliquot was 
withdrawn for display (time zero control; Fig. 7 A, lane 1). 
Another aliquot was incubated, in the presence of 1.5 mM 
ATP and 50 #M Mg  2÷, with desalted extract. At the end of 
this reaction, the mixture was centrifuged through a sucrose 
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ing steps in matrix  complementation.  (A/) Northern  profiles of 
complementation reactions (corn) performed with desalted extract 
in the absence of Mg  2÷ (lane 2) or in the presence of Mg  2+ at the 
indicated concentrations  (lanes 3-11).  Lanes 1 and 12 (to and D) 
are as in previous figures. DL denotes the debranched lariat.  We 
have consistently observed that this species appears in increased 
amounts when the reactions are performed in the presence of very 
low Mg  2+. (A2) Lanes 1 and 3 are as lanes 1 and 2 of A/. In the 
reaction of lane 2, ATP was omitted, whereas the reaction of lane 
4 was performed  in the absence of Mg  2÷ but in the presence  of 
ATP and EDTA (5 mM). (B) Autonomous splicing reactions (aut) 
performed  with  Mg  2÷ at varying concentrations,  as indicated on 
the top of the figure. Lane 1 is the time zero control. 
cushion,  and the pellet was resuspended and divided into 
three aliquots. One of them was processed directly for elec- 
trophoresis to show the accumulation of lariat-exon2 inter- 
mediate (Fig. 7 A, lane 2).  The other two aliquots were in- 
cubated for 30 min under conditions of autonomous splicing, 
one of them in the absence of ATP. The analysis showed that 
the  intermediate  in  the  latter  reaction  did  not  proceed 
through the second splicing step (Fig. 7 A, lane 4). In con- 
trast, when both 0.5 mM Mg  2÷ and 1.5 mM ATP were pres- 
ent, the amount of the previously accumulated lariat-exon2 
intermediate decreased, while free lariat appeared (Fig. 7 A, 
lane  3).  Interestingly,  in  this  particular  experiment,  the 
amount of lariat product was greater than that expected from 
the conversion of the intermediate alone, and was accompa- 
nied by reduction of the amount of precursor (Fig. 7 A; com- 
pare lane 2 with lane 3). This suggests that under conditions 
of low Mg  2÷ SCF associates with the splicing complex, but 
can propagate to  some extent only the  first splicing  step. 
When the Mg  2÷ concentration is then raised, SCF can chase 
the accumulated intermediates into products,  while,  at the 
same time, more precursor is processed through both splic- 
ing steps. 
To provide controls, another aliquot of the salt-washed ma- 
Figure 7. Binding of SCF to matrix-associated splicing complexes 
(A) Northern profiles of the time zero control (lane 1 ) and of RNA 
from high-salt matrix aliquots that were processed as follows. After 
a first incubation (INC1) of reactions, performed  in the presence 
of ATP and Mg  2+ in low concentration  (50 #M), either with de- 
salted extract (DSE; lanes 2-4) or with buffer (B; lanes 5-7), the 
matrix was pelleted through a sucrose cushion. RNA was then ex- 
tracted from aliquots for immediate display (without secondary in- 
cubation, INC2(-); lanes 2 and 5), whereas other aliquots were in- 
cubated further (INC2) either with both ATP and (0.5 mM) Mg  2+ 
(lanes 3 and 6) or with Mg  2+ alone (lanes 4 and 7). (B) Northern 
profile of an aliquot of a reaction incubated with desalted extract 
in the presence of low Mg  2+ (lane 3). Another aliquot of the same 
reaction was diluted 80-fold with splicing buffer containing 0.5 mM 
Mg  2+, and then incubated further (lane 4). Lane 1 is as lane 3, ex- 
cept that the sample is from a parallel mock reaction that was first 
incubated with buffer, instead of desalted extract. Another aliquot 
of the mock reaction was diluted 80-fold and then desalted extract 
(at the same concentration as that in the experiment of lane 4) was 
added before the secondary incubation (lane 2). 
trix was incubated for 30 min with buffer, instead of extract. 
An aliquot of this reaction was processed immediately for 
display (Fig. 7 A, lane 5), and two other aliquots were in- 
cubated for an additional 30 min under conditions of autono- 
mous splicing in the presence or absence of ATP (Fig. 7 A, 
lanes 6 and 7, respectively). Comparison with the time zero 
matrix control (Fig. 7 A, lane 1) demonstrated the absence 
of autonomous reactions in these controls (lanes 5-7). 
To eliminate the possibility that some residual extract was 
trapped during the centrifugation step through the sucrose 
cushion and propagated the second splicing step, we repeated 
the  experiment  described  above,  but  with  the  following 
modification. After incubation with desalted extract for fac- 
tor "pick-up" (experimental  sample),  or with buffer (con- 
trol), aliquots were withdrawn for display (Fig. 7 B, lanes 3 
and  1,  respectively).  The remainder of each reaction was 
then diluted 80-fold with splicing buffer. Addition of extract 
to  the  control  sample at this  time and  further  incubation 
showed  that  SCF  was unable to complement the  splicing 
complexes when diluted 80-fold (Fig. 7 B, lane 2).  In con- 
trast, lariat product did appear in the experimental sample 
that was incubated in the dilute mixture for an additional 30 
rain with both ATP and Mg  2÷ (Fig.  7 B, lane 4),  in agree- 
ment with the results of the previous experiment (Fig. 7 A). 
These data provide additional evidence that SCF is a compo- 
nent of the autonomous spliceosomes. 
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ration with  supernatant  after ul- 
tracentrifugation  of extract.  The 
controls  in  lanes  to and  D  are, 
respectively, the Northern profiles 
of time zero RNA and RNA after 
incubation of the matrix without 
extract  (3 /zl of high-salt  matrix 
per lane). The profile in lane S is 
the  result  of a complementation 
reaction  (50 #1) containing  3 #1 
of matrix  and 30 #1 of superna- 
tant  after  ultracentrifugation  of 
the nuclear extract to remove the 
snRNPs (see Materials and Meth- 
ods).  (B)  Matrix  complementa- 
tion reactions with heat-treated extract. The controls in lanes to and D (2 #1 of high-salt matrix per lane) are the same as in A. The North- 
ern profiles in lanes 1-5 show the results of matrix complementation reactions performed either with untreated extract (lane 1 ) or with 
extract heated at the indicated temperatures  for the indicated times (lanes 2-5). (C) In vitro splicing reactions with heat-treated extract. 
Lanes 1-5, corresponding to the same lanes of B, show the results of in vitro splicing reactions (controls) that were performed using an 
SP6 precursor  containing the rabbit/3 globin gene IVS1 and aliquots of the same heat-treated extracts as in B. 
Nucleoplasmic and Spliceosome-bound SCF 
Using  our  complementation assay,  we  examined  whether 
SCF is also present in the SI00 cytoplasmic fraction. Fig. 5 
A  (lanes  7 and  8)  shows that the  addition  of undiluted  or 
twofold-diluted  S100  fraction  to  matrix  complementation 
reactions resulted in RNA degradation. Upon fourfold dilu- 
tion the nucleolytic activities were not as apparent, and the 
S100 fraction could complement the NM. However, accumu- 
lation of lariat-exon2 intermediate was again observed (Fig. 
5 A,  lane 9),  as with the addition of dilute nuclear extract 
(Fig. 5 A, lane 5). This result suggested that SCF is a soluble 
nucleoplasmic factor that leaks out of the nuclei during ex- 
tract preparation (although the possibility that there is also 
a  cytoplasmic pool  of the  factor  cannot  be  formally  ex- 
cluded). 
Our previous  demonstration of  autonomous splicing  had 
indicated  that  a compartment of spliceosomc-bound  SCF 
should also  exist.  To examine whether this  compartment is 
a  major  source  of  the  complementing activities  present  in  the 
nuclear  extract,  we prepared a  set  of  extract  fractions  by in- 
creasing  sequentially  the  KCI  concentration  (between  0.1  and 
0.6  M, in  0.1  M  increments),  instead  of  extracting  the  nuclei 
in  one  step  with  0.42  M  NaCl (Dignarn  et  al.,  1983).  Assays 
of the fractions  for SCF  activity  and quantitation  of the 
results  (not  shown)  demonstrated that  <I0% of  the  factor  was 
released  in  the  0.1 M  KCI wash. All fractions  up to  0.5 M 
(inclusive)  were active,  but  a sharp  peak of  SCF ("~70% of 
the  total)  was found  in  the  0.3  M  wash. This salt-elution  be- 
havior  of  the  complementing factor  is  in  excellent  correlation 
with that  of matrix preparations  extracted  with increasing 
concentrations  of  salt.  We conclude that  very  little  of  the  free 
nuclcoplasmic form of  SCF is left  in the hypotonic nuclei 
during their  preparation,  because,  otherwise,  most of the 
factor  would have been found in  the first  0.I M  KCI wash. 
Features of SCF 
A feature of the complementation reaction is that it does not 
depend on factors with an RNA component. Previously, we 
showed that nuclear extract that had been treated effectively 
with micrococcal nuclease could still sustain matrix com- 
plementation (Zeitlin et al.,  1987).  However, this result did 
not exclude the participation in the complementation reac- 
tion  of the  nuclease-resistant  U5-snRNP  (Chabot  et  al., 
1985)  or of unknown  resistant  snRNPs.  To eliminate this 
possibility we removed the snRNPs from the nuclear extract 
by ultracentrifugation for 2 h at 356,000 g (see Ruskin et al., 
1988), and showed that the high-speed supernatant was still 
complementation competent (Fig.  8 A, lane S;  compare to 
the other two lanes).  Comparative electrophoretic analysis 
(ethidium bromide staining) of the snRNAs in the superna- 
tant and the pellet fractions showed that occasionally trace 
amounts of U1 and U2 snRNAs can be found in the superna- 
tant, in addition to tRNA (data not shown). On other occa- 
sions,  however,  the  supernatant  was  devoid  of detectable 
snRNAs;  gel electrophoresis of pCp  3' end-labeled RNAs 
from deproteinized aliquots of supernatant and solubilized 
pellet  demonstrated  that  only  the  pellet  yielded  labeled 
snRNA species (not shown). 
To characterize SCF further, we examined its thermal sta- 
bility. Aliquots of splicing extract were incubated on ice, or 
heated at 37°C for either 15 or 45 min, or at 42 or 50°C for 
15 min. Examination of these heated extracts for their ability 
to splice in vitro an SP6 precursor (control reactions) showed 
that even the treatment at 37°C for 45 min impaired splicing 
(Fig.  8  C,  lane 3).  In vitro splicing with extract heated at 
42°C was substantially reduced (Fig. 8 C, lane 4), and was 
abolished by heat treatment at 50°C  (lane 5).  In contrast, 
when the same extracts were used for matrix complementa- 
tion, we observed that treatment at 42°C did not impair com- 
plementation (Fig. 8 B, lane 4), and that a significant portion 
of  the activity survived even the 50°C treatment (lane 5). Ap- 
parently SCF is relatively heat resistant, whereas other, heat- 
sensitive components exist which presumably participate in 
the  in  vitro assembly of spliceosomes,  as previously sug- 
gested (see, for example, Abmayr et al., 1988). In the control 
experiments described above (Fig. 6 C) we observed reduc- 
tion of both splicing steps.  However, in other in vitro SP6 
splicing reactions with heated extracts we had observed on 
occasion extract-dependent accumulation of intermediates, 
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fractions. (A) High-salt matrix (2 pl/25  /zl reaction 
without PVA) was complemented either with the flow- 
through fraction (F~, 16/zl) or with the bound fraction 
(B; 4 td) of DEAE-Sepharose column chromatogra- 
phy after concentration by ammonium sulfate precipi- 
tation (lanes 3 and 4, respectively; see Materials and 
Methods for details). A combination of the two frac- 
tions was used for the reaction in lane 5. The aliquot 
of flowthrough fraction used for the assay shown in 
lane 6was first heated at 55°C for 10 min (AFT). The 
negative and positive control reactions in lanes 1 and 
2, respectively, were performed in the presence of ei- 
ther buffer alone (D) or unfractionated extract (E). 
(B) Lanes 1-3, corresponding to lanes 3-5 of  A, show 
the results of in vitro splicing reactions (controls) that 
were performed using the same SP6 precursor as in 
Fig. 8 C. Each 50 #1 reaction (performed in the pres- 
ence of 2.5% PVA for 2 h at 30°C) contained aliquots 
of  concentrated  chromatographic  fractions:  flow- 
through (24 #l; lane 1), bound (6/zl; lane 2), or a 
combination of the two (lane 3). 
in agreement with other reports (see Reed et al.,  1988; Ab- 
mayr et al.,  1988). For this reason, we examined additional 
extracts in matrix complementation reactions, but the results 
were invariable.  The heat  resistance  of SCF  was  further 
documented in experiments using fractionated extracts (see 
below). Treatment of the extract with N-ethylmaleimide re- 
duced significantly, but did not abolish,  complementation 
(data not shown). 
To correlate SCF with non-snRNP  splicing factors that 
have been described (see Discussion),  we initiated extract 
fractionations, using as a first step DEAE-Sepharose chro- 
matography under conditions identical to those described in 
an advanced fractionation scheme (Kr'arner et al., 1987). We 
found that SCF was present in the flowthrough fraction of  the 
column (Fig. 9 A, lane 3), whereas the bound fraction was 
practically devoid of activity (lane 4).  Addition of bound 
fraction to the flowthrough did not augment the complemen- 
ration level attained with the latter fraction alone (Fig. 9 A, 
lane 5). The SCF activity in the flowthrough was relatively 
heat resistant at 55°C for 10 min (Fig. 9 A, lane 6). 
To demonstrate that the components in the DEAE-Sepha- 
rose-bound fraction were still active, we performed in vitro 
control reactions with an SP6 precursor. Fig. 9 B shows that 
neither the flowthrough nor the bound fraction were active 
in in vitro splicing (lanes 1 and 2,  respectively), but they 
could complement each other (lane 3). 
Discussion 
We have described autonomous splicing reactions occurring 
under  in  vitro  conditions  in  presumptive  complexes  as- 
sociated with a nuclear matrix pellet prepared by extraction 
with  a  physiological concentration of salt.  Using  several 
different LS-NM preparations, we showed that ,025 % of the 
pre-mRNA can be processed autonomously. This level could 
reflect the percentage of complexes that are fully assembled 
and ready to initiate splicing at any time point of the steady- 
state, assuming that the particular complexes that we monitor 
are typical of all spliceosomes. The great majority of the re- 
maining 75 % of the complexes are also functional because 
they can be complemented for splicing with nuclear extract. 
Based on our demonstration of functionality, we propose 
that at least a subset of matrix-bound HnRNPs correspond 
to in vivo spliceosomes of the in situ matrix. This view is 
consistent with  a  previously proposed general hypothesis 
linking  HnRNP particles with pre-mRNA processing (re- 
viewed by Pederson, 1983). Our interpretation relies on ex- 
trapolation from the description of in vitro-assembled spliceo- 
somes because we did not examine directly the structural 
composition of the in vivo complexes. 
The autonomous reactions occur in the matrix or in iso- 
lated nuclei without a temporal lag and are half-complete in 
5 min. This rapid kinetics is a feature consistent with other 
information about  the  in  vivo behavior of splicing  com- 
plexes. In vivo results from electron microscopic analyses 
have indicated that cotranscriptional spliceosome assembly 
(formation of "committed presplicing complexes") might be 
quite common (Beyer and Osheim,  1988).  In a  subset of 
precursors splicing also occurs cotranscriptionally and pre- 
sumably before polyadenylation. The overall time for intron 
removal is ,03 min after the transcriptional synthesis of the 
3' splice site, regardless of intron length in the cases studied 
(Bayer and Osheim, 1988). This estimate reflects the time re- 
quired  for both  spliceosome  assembly  (,02  min;  as  evi- 
denced by the formation of an intron loop) and for the splic- 
ing  reactions  (elimination  of the  loop  "01  min  after  its 
appearance).  By comparison,  our kinetics of autonomous 
splicing,  which measures only the latter, seems somewhat 
retarded. However, the precursor we study presumably be- 
longs to a different category because it is spliced after poly- 
adenylation (Zeitlin et al.,  1987). We note that an earlier in 
vivo estimate  (from a  pulse-chase  experiment) suggested 
that the half-time for removal of either of two introns that are 
eliminated first from the polyadenylated ovomucoid precur- 
sor is of the order of 10 min (Tsai et al.,  1980). An in vivo 
time course study of the splicing intermediates and products 
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snRNP-containing fractions 
SF1 (SF  =  splicing factor; Krainer and Maniatis,  1985) 
II (Furneaux et al.,  1985) 
QU1 (U1  +  U5), QU2 (U2  +  U4/U6) (Kr'~-ner et al.,  1987) 
Non-snRNP  (>rotein 9  splicing factors 
[SP6 assays] 
SF2,  SF3, SF4A,  SF4B (Krainer and Maniatis,  1985)* 
SF*I, SF*2 (50 kD), SF*3, SF*4 (KPAmer  and Keller,  1985; Kriimer 
et al.,  1987)* 
Ia, Ib (Furneaux et al.,  1985; Perkins et al.,  1986) 
[Matrix complementation assays] 
SCF (This paper) 
[RNA-binding assays] 
IBP (100-kD intron binding protein;  Tazi et al.,  1986)* 
3SSBC (70 kD 3' splice site binding component; Gerke and Steitz, 
1986)* 
U2AF (U2 snRNP auxiliary factor;  Ruskin et al.,  1988) 
Factors Present Exclusively in Nuclear Extract 
SF2,  SF*3, SF*4, U2AF 
Factors Present in Both the Nuclear Extract and the SIO0 Fraction 
SF3,  SF4A,  SF4B, SF*I, SF*2, SCF, "IBP'§ 
Heat Sensitivity 
45 °, 10 min: resistant: SF2, SF4A, SF4B, SF*2, Ia (53%), Ib (38%), 
SCF 
sensitive: SF3 (also U2AF; conditions not reported) 
55 °,  10 min: resistant:  Ia (39%),  SCF 
sensitive: Ib 
N-Ethylmaleimide Sensitivity 
Relatively Resistant (reduction, but not elimination, of activity): Ia, 
SCF 
Sensitive: Ib, SF*2, U2AF 
Reactions 
SF1  +  SF2  +  SF3  =  no splicing 
[SF1 +  SF2 +  SF3] +  SF4B =  first step [SF4B is a 1st step factor] 
[SF1 +  SF2 +  SF3 +  SF4B] +  SF4A =  both splicing steps [SF4A 
is a 2rid step factor] 
Heated extract (SF3-)  =  first step [SF3 is a second step factor] 
Ia +  lb  +  II =  both steps 
Ib +  II =  first step [Ia is a second step factor] 
SF*I  +  SF*2 +  SF*3 +  SF*4 +  QUI  +  QU2  =  both steps [un- 
coupling of steps not observed by omission of any of the factors] 
Matrix  +  SCF  =  both steps 
Chromatographic Correlations 
1.  SF*2 binds  to  DEAE-Sepharose;  SF*I  is  in  the  flowthrough 
(application of extract in 0.1 M KCI, 3 mM Mg2+). Under identical 
conditions,  SCF  is in the  flowthrough.  Ia and Ib are  in the  flow- 
through  of a  DEAE-cellulose  column  (application  in  0.2  M  KC! 
without  Mg2+); they  are  fractionated  by Bio-Rex 70 column chro- 
matography. 
2.  U2AF binds to Mono Q, and is eluted with 0.3 M KCi. The be- 
havior of SF*3 is the same.  Further fractionation of SF*3 on Mono 
S indicates that it consists of at least two components. 
Conclusions 
1.  SF*3 and SF*4 are subsets of SF2; U2AF is a subset of SF*3. 
2.  SCF corresponds to SF*I. 
(For details see Discussion.) 
* To avoid confusion from the coincidental use of the same designations for 
different activities by the two groups, we refer to one set of factors as 
SF*I-SF*4 (instead of SF1-SF4). 
* IBP and 3SSBC are not necessarily identical as generally suggested. In 15 
m_M Mg  ~÷, 3SSBC dissociates from snRNPs and does not bind to DEAE- 
Sepharose. The behavior of IBP is the opposite. 
The 70-kD IBP activity described by Ruskin et al. (1988) was purified ac- 
cording to Tazi et al. (1986), but assayed  according  to Gerke and Steitz (1986). 
from the adenovirus-2  E3  transcription  unit has  indicated 
that they begin appearing within  1-2 and 3-4 min,  respec- 
tively,  after  the  synthesis  of the  precursor  (Sittler  et  al., 
1986). 
Within their limitations all of these measurements, includ- 
ing ours, indicate reaction times of the same order of magni- 
tude. Thus, we suggest that the results obtained with the ad- 
vantageous "open" matrix  system,  which is amenable to in 
vitro manipulation,  can be extrapolated  reliably as a  close 
approximation  to  the  behavior  of in  vivo  native  spliceo- 
somes. 
The complementable structures on the matrix might repre- 
sent a graded series of complexes with various degrees of as- 
sembly.  Alternatively,  if rapid  cotranscriptional  assembly 
of presplicing  complexes  (Beyer and  Osheim,  1988)  is  a 
general  phenomenon,  most of our complementable  struc- 
tures might be missing only SCE The same might apply to 
the structures remaining after high-salt extraction. Salt resis- 
tance of spliceosome structure has also been observed with 
the  in vitro splicing  system (see  Grabowski  et al.,  1985). 
Since matrix complementation can be attained with extracts 
devoid  of activities  with  an  RNA  component,  the  salt- 
resistant complexes certainly contain all of the snRNPs par- 
ticipating in splicing. Such complexes, partially stripped of 
some protein component(s),  are not rearranged and can be 
fully restored by complementation. In fact, as discussed be- 
low, most of the known non-snRNP (protein) splicing factors 
(Table  I)  should  also  be present  on the  salt-washed  com- 
plementable  complexes.  We  note  that  in  vitro-assembled 
complementable  complexes,  derived  by interruption  of an 
SP6  splicing  reaction  ~20  min  after  its  initiation  (after 
spliceosome assembly,  but before the appearance  of prod- 
ucts), require for function not only SCF but also other activi- 
ties present in the DEAE-Sepharose-bound fraction (Parent, 
A.,  R.  Wilson,  S.  Zeitlin,  and A.  Efstratiadis,  manuscript 
in preparation). 
The chromatographic behavior of SCF,  which is present 
in the flowthrough fraction after DEAE-Sepharose column 
chromatography, suggests that SCF corresponds to a compo- 
nent  of the  previously  described  (unbound)  factor  SF*I 
(Kriimer et al.,  1987; see Table I). As SF*I, SCF is present 
in both the nuclear extract and the  S100 fraction.  Further 
purification of SF*I has indicated that the fraction contains 
at  least  two  activities,  one  of them  acting  at  the  level  of 
spliceosome assembly (Kr'fimer, 1988). It is unlikely that the 
latter activity is related to SCE 
SCF is  clearly unrelated  to SF2  (Krainer  and  Maniatis, 
1985),  SF*3  and  SF*4  (Kr'arner et al.,  1987),  and  U2AF 
(Ruskin et al.,  1988), all of which are absent from the S100 
fraction,  and to the DEAE-Sepharose-bound 50-kD poly- 
peptide  SF*2  (Kr'amer  and  Keller,  1985;  Kr'amer  et  al., 
1987).  We believe  that  the  heat-sensitive  SF3  component 
(Krainer and Maniatis,  1985), which has been implicated in 
the second splicing step,  is also unrelated to the relatively 
heat-resistant SCE Moreover, we exclude the possibility that 
SCF could be related to the HnRNP C protein (proposed to 
be a splicing factor; Choi et al., 1986). After ultracentrifuga- 
tion, the HnRNP C protein is found exclusively in the pellet 
(Ruskin et al.,  1988), whereas SCF is in the supernatant.  A 
relationship between  SCF and the fraction Ia described by 
Perkins et al. (1986), which is involved in the second splicing 
step, cannot be excluded because of similar heat- and N-eth- 
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graphic correlation is currently missing. A basis for correlat- 
ing SCF with the remaining  first (SF4B)  and  second step 
(SF4A) activities described by Krainer and Maniatis  (1985) 
is not available. 
Our  current  information  is  not  sufficient to  determine 
whether SCF is one or more splicing activities. It is possible 
that SCF is composed of at least two activities,  SCF1  and 
SCF2, involved in the first and second splicing steps, respec- 
tively. Resolution of this issue could facilitate the eventual in- 
terpretation of the uncoupling of the two splicing steps upon 
extract dilution. One model is that the dissociation constant 
of the  SCF2/matrix  complex  is  higher  than  that  of the 
SCF1/matrix  complex (SCF2 has less affinity  for the com- 
plementable  spliceosome  than  SCF1).  Neither  SCF1 nor 
SCF2 could be a limited extract component (see Results). A 
more complicated model based on the same principle is that 
SCF2 can bind to the spliceosome only via SCF1 (in the form 
of an SCF1/SCF2 complex), but the affinity of SCF1 for the 
spliceosome is higher than its affinity for SCF2. If dilution 
promotes dissociation of the SCF1/SCF2 complex, SCF1 can 
still bind to the complementable  spliceosome propagating 
the first splicing step. If, on the other hand,  SCF is a unique 
factor,  it might act as a multimeric protein (for example, a 
dimer). In this model, concerted propagation  of both splic- 
ing steps depends on the presence of the dimer. However, one 
subunit could suffice to promote the first step, either directly 
or by providing an auxiliary function for another component 
already  present on the complementable spliceosome.  The 
postulated dimer need not be a preexisting entity (dissociat- 
ing into subunits upon dilution), but it might be formed after 
independent binding of two monomers to proximal sites of 
the complementable spliceosome. For the moment we can- 
not discriminate between these models, which certainly do 
not exhaust all possibilities. However, the dilution phenome- 
non we described suggests that binding of SCF is an absolute 
prerequisite for the occurrence of at least the second splicing 
step.  If all of the putative  second step factors  were present 
on the complementable spliceosome, uncoupling of the two 
steps after the occurrence of the first would not have been 
observed. 
The function of SCF at the molecular level is unknown. 
As previously pointed out (see Cech and Bass,  1986),  the 
splicing reactions themselves might be catalyzed by RNA. 
In that case,  instead of an enzymatic  activity,  SCF  or its 
potential components might be the last assembly activities to 
become  associated with the  spliceosome,  triggering  some 
conformational change. 
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